Standard Care | Low Risk

Adenosine (ORTHOPLEX ADENOSINE)

Adenosine risk profile, scheduling, and guidance for claims professionals and care workers . Also known as ORTHOPLEX ADENOSINE, ADENOCOR Adenosine 6mg/2mL injection vial, ADENOSCAN adenosine 30mg/10mL injection vial.

Source: TGA, FDA Updated April 2026

Adenosine (brand names: ORTHOPLEX ADENOSINE, ADENOCOR Adenosine 6mg/2mL injection vial, ADENOSCAN adenosine 30mg/10mL injection vial) is classified as Low risk (2 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. FDA approved in the United States. Antiarrhythmic agent used for acute cardiac arrhythmias with cardiovascular effects requiring monitoring.

Key Takeaways

  • TGA Schedule: S4 in Australia
  • Risk level: Low (2 points)

Scheduling and Classification

Jurisdiction Classification Status
Australia (TGA) S4 Not PBS listed
United States (FDA) Rx only FDA approved

Risk Profile

Risk Level Low
Risk Points 2
CNS Depressant No
Respiratory Risk No

Antiarrhythmic agent used for acute cardiac arrhythmias with cardiovascular effects requiring monitoring.

Regulatory and Compliance Guidance

When Adenosine appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.

Australia TGA / PBS / State Schemes

Classified as S4 under the Therapeutic Goods Administration (TGA).

United States FDA / CDC / State WC

FDA approved for use in the United States.

Check this medication against your full medication list

Run a full risk assessment including Adenosine interactions and compliance checks.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.